Skip to content
Open access

Expression of the Human R163C-RYR1 Gain-of-Function Mutation Modified 2,2′,3,5′,6-Pentachlorobiphenyl (PCB 95) Developmental Neurotoxicity in Weanling Mice

Aug 2026 · International Journal of Molecular Sciences · Vol 27, pp. 7801 · 0 citations · 94 references
Medicine

TL;DR

It is demonstrated that PCB 95 caused behavioral deficits coincident with altered patterns of basal and training-induced dendritic arborization and behavioral and dendritic responses to PCB 95 were altered by expression of the human R163C-RYR1 gain-of-function mutation, supporting the involvement of RYR1-dependent mechanisms in PCB 95 DNT in vivo.

Abstract

Epidemiological studies have identified the developing brain as a target of concern for polychlorinated biphenyls (PCBs). In animal models, behavioral deficits caused by developmental exposure to PCBs have been associated with altered patterns of dendritic arborization in functionally relevant brain regions. In vitro studies revealed that PCB 95 promoted dendritic growth in primary rat hippocampal neuron–glia co-cultures via ryanodine receptor 1 (RYR1)-dependent Ca2+ signaling. However, it is not yet known whether RYR1 dysregulation contributes to disruption of dendritic morphogenesis in the intact developing brain or whether PCB 95 affects translationally relevant behavioral endpoints in juvenile animals. To address these data gaps, we assessed Morris water maze (MWM) performance and dendritic arborization of hippocampal CA1 pyramidal neurons in C57BL/6 mice heterozygous for the human R163C-RYR1 gain-of-function mutation (HET) and congenic wildtype (WT) littermates exposed to vehicle or PCB 95 at 0.1, 1.0, or 6.0 mg/kg/d in the dam’s diet from conception through weaning. MWM performance was not altered in HET vehicle controls relative to WT vehicle controls; however, compared to genotype-matched vehicle controls, spatial learning was impaired in WT and HET male and female weanlings in the 1.0 mg/kg/d PCB 95 dose group and WT males in the 6.0 mg/kg/d PCB 95 dose group. Spatial memory was altered only in WT females exposed to 1.0 or 6.0 mg/kg/d PCB 95. Sholl analyses of Golgi-stained hippocampal neurons in male and female WT and HET weanlings from the 1.0 mg/kg/d PCB 95 and vehicle groups indicated that relative to WT vehicle controls, basal dendritic arborization was significantly increased in HET vehicle controls and in PCB 95-exposed WT weanlings; however, PCB 95 did not alter basal dendritic growth in HET weanlings relative to genotype-matched vehicle controls. PCB 95 significantly reduced training-induced dendritic arborization in WT but not HET weanlings. Measurement of tritiated ryanodine ([3H]Ry) binding in cortical tissue from these same animals revealed interactions between genotype, PCB 95 exposure, and dose that altered [3H]Ry binding relative to WT vehicle controls. Quantitative analyses confirmed a dose-dependent increase in PCB tissue burden that was not significantly altered by genotype, MWM training, or sex. Serum levels of progesterone, estradiol, cortisol, and thyroid hormone (TH) and brain transcript levels of TH-responsive genes were not significantly altered by genotype or PCB 95 dose. These data demonstrate that PCB 95 caused behavioral deficits coincident with altered patterns of basal and training-induced dendritic arborization. Furthermore, behavioral and dendritic responses to PCB 95 were altered by expression of the human R163C-RYR1 gain-of-function mutation, supporting the involvement of RYR1-dependent mechanisms in PCB 95 DNT in vivo.

Read PDF

Similar papers

Open access Sep 2026

Gene therapy with doxycycline-controlled expression of human Kv1.1 reduces neuronal excitability and increases sociability of Scn2a-deficient mice

Genetic loss-of-function (LoF) variants in SCN2A, a gene encoding the voltage-gated sodium channel Nav1.2, have been identified as one of the foremost monogenic causes of autism spectrum disorder (ASD). ASD encompasses a broad spectrum of behavioral phenotypes, with impaired sociability as a core characteristic. We hav...

Brody A. Deming, Jing-Liang Zhang, Iuliia Vitko et al. · 0 citations
Open access Sep 2026

Effects of MC-100093, GLT-1 enhancer, in mesolimbic brain regions of C57BL/6 mouse exposed to hydrocodone high-dose challenge using comprehensive laboratory monitoring system

Chronic exposure and overdose of opioid cause neurotoxicity through alterations of several neurotransmitters, including glutamate. Upregulating glutamate transporter 1 (GLT-1) has been shown to attenuate the behavioral and neurochemical effects of chronic exposure to drugs of abuse. This study investigated the effects...

W. Wong, K. K. Bhowmik, W. Childers et al. · 0 citations
Open access Sep 2026

Systematic characterization of subchronic MK-801 administration across mouse strains identifies conserved synaptic alterations and a clear cognitive phenotype in C57BL/6J mice.

BACKGROUND The N-methyl-d-aspartate (NMDA) receptor hypofunction hypothesis is central to schizophrenia, yet pharmacological MK-801 models exhibit variability across strains and conditions. We systematically compared behavioral and synaptic phenotypes induced by subchronic MK-801 administration across commonly used mou...

Fumiko Yoshimachi, Minori Ikuta, K. Kimura et al. · 0 citations
Open access Aug 2026

Dysfunction of the RAR/RXR Signaling Pathway in the Mouse Forebrain Reduces GluA1, PSD-95, and ARP3 Expression in the Hippocampus.

Retinoic acid (RA), a biologically active metabolite of vitamin A, regulates gene expression through retinoic acid receptor/retinoid X receptor (RAR/RXR)-dependent transcription and is important for various biological phenomena. To understand the role of forebrain RA signaling in synaptic plasticity and memory, we gene...

Masanori Nomoto, Koji Mitsuda, Shusaku Uchida et al. · 0 citations
Open access Sep 2026

Functional coupling between MC4R and Kir7.1 contributes to clozapine-induced weight gain in female mice

Most antipsychotic drugs (APDs) cause hyperphagia and weight gain, yet the neural mechanisms underlying these metabolic side effects remain elusive, in part due to difficulties in modeling them in rodents. Here, we establish a mouse model that recapitulates clozapine-induced metabolic syndrome, enabling mechanistic inv...

Li Li, Ciria C. Hernandez, L. E. Gimenez et al. · 0 citations
Open access Sep 2026

A De Novo, Intragenic Modifier in Cis Rescues Scn8a-N1768D Epilepsy and Defines a Therapeutic Window Bounded by Gain- and Loss-of-Function

A de novo, intragenic frameshift variant titrates NaV1.6 through a Goldilocks window in which intermediate reduction rescues Gain-of-function epilepsy, whereas insufficient or excessive reduction remains lethal, validating Scn8a-lowering and its therapeutic dose window.

Erfan Bahramnejad, Victor J. Hiller, Michael F. Hammer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.